Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Mohammad Bohlooly-Y
AstraZeneca Pharmaceuticals - IMED Biotech Unit
Mölndal
Sweden
Contact
AstraZeneca Pharmaceuticals - IMED Biotech Unit
Email
Tel: +46-31-7064181
Learn more about SSRN Profiles
SCHOLARLY PAPERS
3
DOWNLOADS
159
TOTAL CITATIONS
1
Feedback
Scholarly Papers (3)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
PCSK9
rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD
Number of pages: 34
Posted: 19 May 2020
Stefania Grimaudo
,
Stefano Bartesaghi
,
Raffaela Rametta
,
Fabio Della Marra
,
Rosellina Margherita Mancina
,
Jussi Pihlajamäki
,
Dorota Kakol-Palm
,
Anne-Christine Andréasson
,
Paola Dongiovanni
,
Anna Ludovica Fracanzani
,
Giulia Lori
,
Ville Männistö
,
Giovanni Pellegrini
, Mohammad Bohlooly-Y,
Grazia Pennisi
,
Rosaria Maria Pipitone
,
Rocco Spagnuolo
,
Antonio Craxì
,
Daniel Lindén
,
Luca Valenti
,
Stefano Romeo
and
Salvatore Petta
- Section of Gastroenterology and Hepatology, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Parma - Dipartimento di Economia, University of Gothenburg - Department of Molecular and Clinical Medicine, University of Eastern Finland - Department of Clinical Nutrition, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca Pharmaceuticals - Bioscience Cardiovascular, Research and Early Development Cardiovascular, Renal and Metabolism, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Florence - Department of Experimental and Clinical Medicine, University of Eastern Finland - Department of Medicine,
affiliation not provided to SSRN
, AstraZeneca Pharmaceuticals - IMED Biotech Unit, - Section of Gastroenterology and Hepatology, - Biomedical Department of Internal and Specialized Medicine (DI.BI.M.I.S.), Magna Graecia University of Catanzaro - Department of Experimental and Clinical Medicine, - Section of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, University of Milan - Department of Pathophysiology and Transplantation, University of Gothenburg - Department of Molecular and Clinical Medicine and - Section of Gastroenterology and Hepatology
Downloads
83
(783,685)
View PDF
Download
Abstract:
NASH, NAFLD, FIBROSIS, PCSK9
2.
Network Analyses Links Epicardial Fat Metabolism to Human Coronary Heart Disease
Number of pages: 37
Posted: 16 Apr 2021
Stephen Doran
,
Muhammad Arif
,
Maryam Clausen
,
Johannes Wikström
, Mohammad Bohlooly-Y,
Anders Jeppsson
,
Malin Levin
,
Adil Mardinoglu
and
Jan Boren
King’s College London - Centre for Host-Microbiome Interactions, Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab), AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca Pharmaceuticals - IMED Biotech Unit, University of Gothenburg - Department of Molecular and Clinical Medicine, University of Gothenburg - Department of Molecular and Clinical Medicine, Royal Institute of Technology (KTH) - Science for Life Laboratory (SciLife Lab) and University of Gothenburg - Department of Molecular and Clinical Medicine
Downloads
52
(1,041,696)
View PDF
Download
Abstract:
3.
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates A1-Antitrypsin Deficiency Phenotype
Number of pages: 32
Posted: 08 Apr 2018
Mikael Bjursell
,
Michelle J Porritt
,
Elke Ericson
,
Amir Taheri-Ghahfarokhi
,
Maryam Clausen
,
Lisa Magnusson
,
Therese Admyre
,
Roberto Nitsch
,
Lorenz Mayr
,
Leif Aasehaug
,
Frank Seeliger
,
Marcello Maresca
, Mohammad Bohlooly-Y and
John Wiseman
AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit, AstraZeneca Pharmaceuticals - IMED Biotech Unit and AstraZeneca Pharmaceuticals - IMED Biotech Unit
Downloads
24
(1,399,036)
Citation
1
View PDF
Download
Abstract:
Feedback